ABSTRACT

FDA Combating COVID-19 with Therapeutics   [open pdf - 624KB]

From the Document: "Since the beginning of the COVID-19 [coronavirus disease 2019] pandemic, the FDA has been working to facilitate development and availability of therapeutics for use by patients, physicians and health systems as expeditiously and safely as possible. In order to facilitate the development of potential COVID-19 treatments FDA created the Coronavirus Treatment Acceleration Program (CTAP), a new program designed to expedite the development of potential COVID-19 therapies by using every tool at the agency's disposal to determine if the therapies are safe and effective for their intended uses. Several therapies are currently being tested in clinical trials to evaluate whether they are safe and effective in combating COVID-19."

Publisher:
Date:
2020-05-11
Series:
Copyright:
Public Domain
Retrieved From:
US Food and Drug Administration: https://www.fda.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations